| General Information of Drug Metabolite (DM) (ID: DM000049) |
| DM Name |
Almotriptan malate metabolite M1
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Monoamine oxidase type A (MAO-A)
|
DME0044
|
| Oxidation - Oxidative Deamination |
Almotriptan malate
|
[1] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
Aldehyde dehydrogenase 1 (ALDH1)
|
DME0286
|
| Other reaction - Dehydration |
Almotriptan malate
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Almotriptan malate |
DR0070
|
Approved |
Migraine |
|
|
| References |
| 1 |
Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine. Clin Pharmacokinet. 2005;44(3):237-46.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
